TY - JOUR
T1 - Changes in accumbal and pallidal pCREB and ΔFosB in morphine-sensitized rats
T2 - Correlations with receptor-evoked electrophysiological measures in the ventral pallidum
AU - McDaid, John
AU - Dallimore, Jeanine E.
AU - Mackie, Alexander R.
AU - Napier, T. Celeste
N1 - Funding Information:
We thank Fei Shen for her help in obtaining electrophysiological data for this study. This study was supported by the Ralph and Marian Falk Medical Research Trust (JM and TCN) and the Irene Whitney Foundation through the Neuroscience & Aging Institute Loyola University Chicago (TCN), and USPHSGs DA05255 and DA015760 (TCN).
PY - 2006/6
Y1 - 2006/6
N2 - Activation of μ-opioid receptors in the ventral pallidum (VP) is important for the induction of behavioral sensitization to morphine in rats. The present study was designed to ascertain if neurons within the VP demonstrate sensitization at a time when morphine-induced behavioral sensitization occurred (ie 3 or 14 days after five once-daily injections of 10 mg/kg i.p. morphine) in rats. Western blotting was used to evaluate transcription factors altered by opiates, CREB and ΔFosB. CREB levels did not change in the VP, but there was a significant decrease in levels of its active, phosphorylated form (pCREB) at both 3- and 14-days withdrawal. ΔFosB levels were elevated following a 3-day withdrawal, but returned to normal by 14 days. This profile also was obtained from nucleus accumbens tissue. In a separate group of similarly treated rats, in vivo electrophysiological recordings of VP neuronal responses to microiontophoretically applied ligands were carried out after 14-days withdrawal. The firing rate effects of local applications of morphine were diminished in rats withdrawn from i.p. morphine. Repeated i.p. morphine did not alter GABA-mediated suppression of firing, or the rate enhancing effects of the D1 dopamine receptor agonist SKF82958 or glutamate. However, VP neurons from rats withdrawn from repeated i.p. morphine showed a higher propensity to enter a state of depolarization inactivation to locally applied glutamate. Overall, these findings reveal that decreased pCREB in brain regions such as the VP accompanies persistent behavioral sensitization to morphine and that this biochemical alteration may influence the excitability of neurons in this brain region.
AB - Activation of μ-opioid receptors in the ventral pallidum (VP) is important for the induction of behavioral sensitization to morphine in rats. The present study was designed to ascertain if neurons within the VP demonstrate sensitization at a time when morphine-induced behavioral sensitization occurred (ie 3 or 14 days after five once-daily injections of 10 mg/kg i.p. morphine) in rats. Western blotting was used to evaluate transcription factors altered by opiates, CREB and ΔFosB. CREB levels did not change in the VP, but there was a significant decrease in levels of its active, phosphorylated form (pCREB) at both 3- and 14-days withdrawal. ΔFosB levels were elevated following a 3-day withdrawal, but returned to normal by 14 days. This profile also was obtained from nucleus accumbens tissue. In a separate group of similarly treated rats, in vivo electrophysiological recordings of VP neuronal responses to microiontophoretically applied ligands were carried out after 14-days withdrawal. The firing rate effects of local applications of morphine were diminished in rats withdrawn from i.p. morphine. Repeated i.p. morphine did not alter GABA-mediated suppression of firing, or the rate enhancing effects of the D1 dopamine receptor agonist SKF82958 or glutamate. However, VP neurons from rats withdrawn from repeated i.p. morphine showed a higher propensity to enter a state of depolarization inactivation to locally applied glutamate. Overall, these findings reveal that decreased pCREB in brain regions such as the VP accompanies persistent behavioral sensitization to morphine and that this biochemical alteration may influence the excitability of neurons in this brain region.
KW - Addiction
KW - D1 dopamine receptor
KW - GABA
KW - Glutamate
KW - Opiates
KW - Transcription factors
UR - http://www.scopus.com/inward/record.url?scp=33745639468&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33745639468&partnerID=8YFLogxK
U2 - 10.1038/sj.npp.1300854
DO - 10.1038/sj.npp.1300854
M3 - Article
C2 - 16123760
AN - SCOPUS:33745639468
SN - 0893-133X
VL - 31
SP - 1212
EP - 1226
JO - Neuropsychopharmacology
JF - Neuropsychopharmacology
IS - 6
ER -